Sjoquist KM, Martin A, Pavlakis N, Goldstein D, et al. Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer. J Cancer Res Clin Oncol 2022 Oct 31. pii: 10.1007/s00432-022-04404.
PMID: 36310299